Benefits and risks of early antiretroviral therapy for HIV
Early antiretroviral therapy may offer benefits to people with HIV who have a CD4+ cell count greater than 350 and do not have symptoms.1, 2 You should not start antiretroviral therapy until you have considered the following benefits and risks and discussed all the issues with your doctor.
|Type of therapy||
Early therapy: Treatment with antiretroviral medicines before CD4+ cell count drops below 350 or before HIV-related symptoms develop
Delayed therapy: Treatment with antiretroviral medicines after CD4+ cell count drops below 350 or after HIV-related symptoms develop
- U.S. Department of Health and Human Services (2008). Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Available online: http://www.aidsinfo.nih.gov/ContentFiles/AdultandAdolescentGL.pdf.
- Hammer, Scott M, et al. (2008). Antiretroviral treatment of adult HIV infection: 2008 recommendations of the International AIDS Society USA Panel. JAMA, 300 (5): 555–570.
Last Updated: April 10, 2009